Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen
- PMID: 3677123
- PMCID: PMC11038389
- DOI: 10.1007/BF00199147
Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen
Abstract
Melanoma high molecular weight tumor-associated antigen (TAA), having a molecular weight of 250 kilodaltons (Kd), was purified from a crude cell membrane extract through a combination of lectin affinity, immunoadsorption, and high performance liquid molecular filtration chromatography. Compared to the starting extract, purified TAA was 600-fold higher in TAA activity per microgram of protein. Purified TAA was used to immunize a chimpanzee and the resulting antiTAA immune response was evaluated. Postimmune chimpanzee serum reacted in solid phase radioimmunoassay against purified TAA with a titer in excess of 100,000. In contrast, preimmune serum had a titer of less than 100 in the same assay. By immunoprecipitation analysis, we were able to demonstrate reactivity of the chimpanzee immune serum with a 250 Kd TAA in spent culture medium from melanoma cells metabolically labeled with 35S-methionine and with iodinated purified 250 Kd TAA. Reactivity of the chimpanzee antiserum for the 250 Kd TAA was confirmed in blocking and reciprocal immunodepletion studies using murine monoclonal antibody 9.2.27. These studies suggest that the 250 Kd TAA defined by murine monoclonal antibodies may prove to be immunogenic in man and that manipulation of the immune response to this TAA might be used to the clinical benefit of the patient.
Similar articles
-
Serological response of non-human primates to human melanoma disialoganglioside GD3.Cancer Immunol Immunother. 1989;29(3):205-10. doi: 10.1007/BF00199997. Cancer Immunol Immunother. 1989. PMID: 2731185 Free PMC article.
-
D6.1, a murine antimelanoma monoclonal antibody from congenitally athymic nude mice immunized with purified melanoma tumor-associated antigen.Hybridoma. 1984 Winter;3(4):333-46. doi: 10.1089/hyb.1984.3.333. Hybridoma. 1984. PMID: 6396196
-
Identification and isolation of melanoma-associated antigens with monoclonal antibodies.Hybridoma. 1982;1(4):413-21. doi: 10.1089/hyb.1.1982.1.413. Hybridoma. 1982. PMID: 6765324
-
In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.Ann Surg. 1981 Nov;194(5):592-601. doi: 10.1097/00000658-198111000-00007. Ann Surg. 1981. PMID: 6895297 Free PMC article.
-
Clinical significance and nature of circulating immune complexes in melanoma patients.Contemp Top Immunobiol. 1985;15:1-53. doi: 10.1007/978-1-4684-4931-0_1. Contemp Top Immunobiol. 1985. PMID: 3896641 Review. No abstract available.
Cited by
-
Serological response of non-human primates to human melanoma disialoganglioside GD3.Cancer Immunol Immunother. 1989;29(3):205-10. doi: 10.1007/BF00199997. Cancer Immunol Immunother. 1989. PMID: 2731185 Free PMC article.
-
Natural pathology of the captive chimpanzee (Pan troglodytes): A 35-year review.J Med Primatol. 2017 Oct;46(5):271-290. doi: 10.1111/jmp.12277. Epub 2017 May 23. J Med Primatol. 2017. PMID: 28543059 Free PMC article. Review.
References
-
- Carrel S, Accolla RS, Carmagnola AL, Mach JP. Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res. 1980;40:2523–2528. - PubMed
-
- Casellas P, Brown JP, Gros O, Gros P, Hellstrom I, Jansen FK, Poncelet P, Roncucci R, Vidal H, Hellstrom KE. Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p 97. Int J Cancer. 1982;30:437–443. - PubMed
-
- Cassel WA, Murray DR, Torbin AH, Olkowski ZL, Moore ME. Viral oncolysate in the management of malignant melanoma. Cancer. 1977;40:672–679. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical